Astromech raises $20M to build a biological operating system that can forecast evolutionary change - SiliconANGLE

Astromech raised $20mn at a $3.8bn valuation

Astromech raised $20mn at $3.8bn to forecast biological evolution via ancestral regulatory reconstruction trained on 3.8bn years of evolutionary data. Upstream of drug discovery for pathogen and drug-resistance forecasting, but all results retrospective—only 46 known genes recovered; prospective validation through partner pilots still pending.